{
  "title": "Spatially resolved transcriptomics reveal the determinants of primary resistance to immunotherapy in NSCLC with mature tertiary lymphoid structures.",
  "pmid": "39909044",
  "doi": null,
  "affiliations": [
    "Department of Medicine, Institut Bergonié, Bordeaux, France; Faculty of Medicine, University of Bordeaux, Bordeaux, France; Explicyte Immuno-Oncology, Bordeaux, France.",
    "Explicyte Immuno-Oncology, Bordeaux, France.",
    "Explicyte Immuno-Oncology, Bordeaux, France.",
    "Explicyte Immuno-Oncology, Bordeaux, France.",
    "Explicyte Immuno-Oncology, Bordeaux, France.",
    "Atlantic Pathologie, Saint-Pierre-d'Irube, France.",
    "Department of Pathology, Institut Bergonié, Bordeaux, France.",
    "Faculty of Medicine, University of Bordeaux, Bordeaux, France; Department of Pathology, Institut Bergonié, Bordeaux, France.",
    "Centre Hospitalier de la Côte Basque, Bayonne, France.",
    "Department of Medicine, Institut Bergonié, Bordeaux, France.",
    "Centre Hospitalier de la Côte Basque, Bayonne, France.",
    "Clinique Marzet, Pau, France.",
    "Clinique Marzet, Pau, France.",
    "Department of Cancer Immunology, Genentech, A member of the imCORE Network, South San Francisco, CA, USA; DITEP, Gustave Roussy, Villejuif, France.",
    "Explicyte Immuno-Oncology, Bordeaux, France.",
    "Department of Medicine, Institut Bergonié, Bordeaux, France; Faculty of Medicine, University of Bordeaux, Bordeaux, France; DITEP, Gustave Roussy, Villejuif, France. Electronic address: a.italiano@bordeaux.unicancer.fr."
  ]
}